We are updating our Privacy Policy and Terms and Conditions to help you clearly understand how your personal information is collected, stored and managed. Learn More
Menu Back toA-Hot-Debate-Perspectives-on-Benefit-Risk-From-Patients-Across-Diseases

DIA 2018 Global Annual Meeting

The DIA 2018 Global Annual Meeting brings together thousands of innovators from around the globe.

A Hot Debate: Perspectives on Benefit and Risk From Patients Across Diseases

    Session Chair(s)
      Deborah E. Collyar

      Deborah E. Collyar

      • President
      • Patient Advocates In Research (PAIR), United States
    This session provides a look at how regulators, companies, and patients can work together to discuss the benefits and risks of emerging products that can lead to better patient outcomes.
    Learning Objective : 1) Develop an understanding of how patient preferences can be used to inform benefit-risk assessments 2) Develop an understanding of the properties of patient preference methods and the implications of these properties for use of patient preference information for regulatory purposes
      Dinah  Duarte, PharmD, MSc

      Benefit- Risk Communication: Lessons from Patients

      Dinah Duarte, PharmD, MSc

      • Scientific Evaluation Unit, Directorate of Medicinal Products
      • INFARMED, Portugal
      Rebecca A. Noel, DrPH

      PREFERing to Advocate for Patient Preferences

      Rebecca A. Noel, DrPH

      • Global Benefit-Risk Lead, Global Patient Safety
      • Eli Lilly and Company, United States
      Marlo  Schepper

      Living with Tuberous Sclerosis Complex (TSC): A Case Study

      Marlo Schepper

      • Volunteer
      • Tuberous Sclerosis Alliance, United States